GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medlive Technology Co Ltd (HKSE:02192) » Definitions » ROA %

Medlive Technology Co (HKSE:02192) ROA % : 5.92% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Medlive Technology Co's annualized Net Income for the quarter that ended in Jun. 2024 was HK$315.9 Mil. Medlive Technology Co's average Total Assets over the quarter that ended in Jun. 2024 was HK$5,336.7 Mil. Therefore, Medlive Technology Co's annualized ROA % for the quarter that ended in Jun. 2024 was 5.92%.

The historical rank and industry rank for Medlive Technology Co's ROA % or its related term are showing as below:

HKSE:02192' s ROA % Range Over the Past 10 Years
Min: 1.87   Med: 12.67   Max: 51.03
Current: 5.9

During the past 6 years, Medlive Technology Co's highest ROA % was 51.03%. The lowest was 1.87%. And the median was 12.67%.

HKSE:02192's ROA % is ranked better than
72.23% of 677 companies
in the Healthcare Providers & Services industry
Industry Median: 1.58 vs HKSE:02192: 5.90

Medlive Technology Co ROA % Historical Data

The historical data trend for Medlive Technology Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co ROA % Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial 33.77 51.03 1.87 2.57 5.05

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1.25 3.94 4.12 5.87 5.92

Competitive Comparison of Medlive Technology Co's ROA %

For the Health Information Services subindustry, Medlive Technology Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's ROA % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medlive Technology Co's ROA % distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's ROA % falls into.



Medlive Technology Co ROA % Calculation

Medlive Technology Co's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=265.024/( (5140.494+5352.753)/ 2 )
=265.024/5246.6235
=5.05 %

Medlive Technology Co's annualized ROA % for the quarter that ended in Jun. 2024 is calculated as:

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=315.898/( (5352.753+5320.561)/ 2 )
=315.898/5336.657
=5.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2024) net income data. ROA % is displayed in the 30-year financial page.


Medlive Technology Co  (HKSE:02192) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=315.898/5336.657
=(Net Income / Revenue)*(Revenue / Total Assets)
=(315.898 / 524.154)*(524.154 / 5336.657)
=Net Margin %*Asset Turnover
=60.27 %*0.0982
=5.92 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Medlive Technology Co ROA % Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians who make procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Executives
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
M3, Inc. 2101 Beneficial owner
Sony Group Corporation 2201 Interest of corporation controlled by you
Tian Liping
Zhang Xiaofeng 2101 Beneficial owner
Liu Lingdi 2101 Beneficial owner
Tian Lixin 2101 Beneficial owner
Brown Brothers Harriman & Co. 2502 Approved lending agent
Fidelity Funds 2101 Beneficial owner
Tiantian Co., Limited

Medlive Technology Co Headlines

No Headlines